Source: Annual Congress 2011 - Quality management for lung cancer patients
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. S. Strimpakos, E. Patsourou, D. Pouli, C. Fevranoglou, I. Giozos, A. Charpidou, K. N. Syrigos (Athens, Greece). The role of chemotherapy re-challenge in non small cell lung cancer. A retrospective study in a tertiary general hospital and thoracic center. Eur Respir J 2011; 38: Suppl. 55, 4422

Member's Comments

No comment yet.

Related content which might interest you: A retrospective clinical review of drug induced interstitial lung disease at a tertiary cancer centre Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 A prospective observational study on 10770 patients with lung disorder visiting the pulmonary specialist in a regional hospital, with special emphasis on 703 patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care? Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Determining the perception of lung cancer screening programme amongst medical patients in single tertiary centre. Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 How do patient and hospital features influence outcomes in small cell lung cancer in England? Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Salvage treatment in patients with recurrent or resistant malignant pleura mesothelioma. A retrospective study from tertiary oncology department Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Long time survival after resection for multiple primary lung cancers. A population-based study Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 A retrospective analysis of patient presentation to primary and secondary care prior to subsequent late stage lung cancer diagnosis Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Retrospective study of a one-stop lung cancer clinic in a district general hospital over a 2-year period Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 A comparison of patients from a regional multi disciplinary team referred for surgical lung cancer treatment Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017 Predictors of long time mortality after lung cancer surgery. A retrospective cohort study Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008 External comparison of hospitals concerning quality of oncological care of patients with lung cancer in an outcome evaluation study from a population-based regional cancer registry Source: Eur Respir J 2001; 18: Suppl. 33, 438s Year: 2001 Centralisation of thoracic surgery services to a regional centre – the impact on cancer waiting times Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT) Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 Multidisciplinary management of interstitial lung diseases in a tertiary centre: A prospective study. Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 The causes and consequences for dose reduction in NSCLC IIIB patients, a retrospective single center clinical trial. Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Chemotherapy induced neutropenia in lung cancer patients: a single centre study Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting Source: Eur Respir J 2002; 20: Suppl. 38, 399s Year: 2002